Triglycerides Revisited to the Serial

Adv Clin Chem. 2017;80:1-44. doi: 10.1016/bs.acc.2016.11.001. Epub 2017 Jan 3.


This review discusses the role of triglycerides (TGs) in the normal cardiovascular system as well as in the development and clinical manifestation of cardiovascular diseases. Regulation of TGs at the enzymatic and genetic level, in addition to their possible relevance as preclinical and clinical biomarkers, is discussed, culminating with a description of available and emerging treatments. Due to the high complexity of the subject and the vast amount of material in the literature, the objective of this review was not to exhaust the subject, but rather to compile the information to facilitate and improve the understanding of those interested in this topic. The main publications on the topic were sought out, especially those from the last 5 years. The data in the literature still give reason to believe that there is room for doubt regarding the use of TG as disease biomarkers; however, there is increasing evidence for the role of hypertriglyceridemia on the atherosclerotic inflammatory process, cardiovascular outcomes, and mortality.

Keywords: Atherosclerosis; Biomarkers; Coronary artery disease; Hypertriglyceridemia; Treatment.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases*
  • Cardiovascular Physiological Phenomena*
  • Gene Expression Regulation
  • Humans
  • Hypertriglyceridemia / drug therapy
  • Hypertriglyceridemia / etiology
  • Hypolipidemic Agents
  • Triglycerides / metabolism*


  • Hypolipidemic Agents
  • Triglycerides